MERCK & CO., INC. (MRK)
Clinical trial NCT04924075 updates: 1. completion date: 2029-06-04 → 2029-12-27 2. primary completion date: 2029-06-04 → 2029-12-27 3. enrollment: 322 → 355 participants
Clinical trial NCT04924075 updates: 1. completion date: 2029-06-04 → 2029-12-27 2. primary completion date: 2029-06-04 → 2029-12-27 3. enrollment: 322 → 355 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical